Myriad Genetics, Inc.
GB ˙ LSE ˙ US62855J1043
4,65 $ ↓ -0,01 (-0,17%)
2026-06-05
DEL PRIS
SecurityGB:0K3W / Myriad Genetics, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership70,241 shares
Latest Disclosed Value $ 316,085
Creative Planning ownership in 0K3W / Myriad Genetics, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 70,241 shares of Myriad Genetics, Inc. (GB:0K3W) valued at $308,358 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 73,738 shares of Myriad Genetics, Inc.. This represents a change in shares of -4.74% during the quarter. The current value of the position is $326,761 USD.

Creative Planning has a history of taking positions in derivatives of the underlying security (0K3W) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0K3W / Myriad Genetics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F MYRIAD GENETICS COM 62855J104 70,241 -3,497 -4.74 316 -30.24 0.0002
2026-02-17 2025-12-31 13F MYRIAD GENETICS COM 62855J104 73,738 -3,979 -5.12 453 -19.25 0.0003
2025-11-14 2025-09-30 13F MYRIAD GENETICS COM 62855J104 77,717 43,794 129.10 562 211.67 0.0004
2025-08-08 2025-06-30 13F MYRIAD GENETICS COM 62855J104 33,923 9,804 40.65 180 -15.49 0.0002
2025-05-15 2025-03-31 13F MYRIAD GENETICS COM 62855J104 24,119 24,050 34,855.07 214 0.0002
2025-02-14 2024-12-31 13F MYRIAD GENETICS COM 62855J104 69 -9,880 -99.31 1 -100.00 0.0000
2024-10-11 2024-09-30 13F MYRIAD GENETICS COM 62855J104 9,949 892 9.85 273 23.08 0.0003
2024-08-15 2024-06-30 13F MYRIAD GENETICS COM 62855J104 9,057 9,057 222 0.0002
2020-05-05 2020-03-31 13F MYRIAD GENETICS COM 62855J104 0 -8,951 -100.00 0 -100.00
2020-01-30 2019-12-31 13F MYRIAD GENETICS COM 62855J104 8,951 700 8.48 244 3.39 0.0007
2019-11-01 2019-09-30 13F MYRIAD GENETICS COM 62855J104 8,251 8,251 236 0.0008
2019-07-26 2019-06-30 13F MYRIAD GENETICS COM 62855J104 0 -7,500 -100.00 0 -100.00
2019-04-24 2019-03-31 13F MYRIAD GENETICS COM 62855J104 7,500 -433 -5.46 249 7.79 0.0009
2019-02-12 2018-12-31 13F/A-1 MYRIAD GENETICS COM 62855J104 7,933 2,150 37.18 231 -13.16 0.0009
2019-02-01 2018-12-31 13F MYRIAD GENETICS COM 62855J104 7,933 2,150 231
2018-10-25 2018-09-30 13F MYRIAD GENETICS COM 62855J104 5,783 5,783 266 0.0010
2018-04-18 2018-03-31 13F MYRIAD GENETICS COM 62855J104 0 -6,894 -100.00 0 -100.00
2018-01-17 2017-12-31 13F MYRIAD GENETICS COM 62855J104 6,894 -389 -5.34 237 -9.89 0.0010
2017-10-17 2017-09-30 13F MYRIAD GENETICS COM 62855J104 7,283 1,083 17.47 263 64.38 0.0012
2017-07-12 2017-06-30 13F MYRIAD GENETICS COM 62855J104 6,200 -171 -2.68 160 31.15 0.0008
2017-04-07 2017-03-31 13F MYRIAD GENETICS COM 62855J104 6,371 671 11.77 122 28.42 0.0007
2017-01-09 2016-12-31 13F MYRIAD GENETICS COM 62855J104 5,700 0 0.00 95 -18.80 0.0006
2016-10-12 2016-09-30 13F MYRIAD GENETICS COM 62855J104 5,700 0 0.00 117 -32.76 0.0007
2016-07-12 2016-06-30 13F MYRIAD GENETICS COM 62855J104 5,700 0 0.00 174 -18.31 0.0013
2016-04-08 2016-03-31 13F MYRIAD GENETICS COM 62855J104 5,700 -200 -3.39 213 -16.47 0.0017
2016-01-11 2015-12-31 13F MYRIAD GENETICS COM 62855J104 5,900 -100 -1.67 255 13.33 0.0021
2015-10-09 2015-09-30 13F MYRIAD GENETICS COM 62855J104 6,000 6,000 0.00 225 0.0020
2015-07-09 2015-06-30 13F MYRIAD GENETICS COM 62855J104 0 -6,250 -100.00 0 -100.00
2015-04-13 2015-03-31 13F MYRIAD GENETICS COM 62855J104 6,250 6,250 0.00 221 0.0021
2015-01-29 2014-12-31 13F MYRIAD GENETICS COM 62855J104 0 -5,819 -100.00 0 -100.00
2014-10-10 2014-09-30 13F MYRIAD GENETICS COM 62855J104 5,819 -2,321 -28.51 224 -29.34 0.0026
2014-08-20 2014-06-30 13F MYRIAD GENETICS COM 62855J104 8,140 -100 -1.21 317 12.41 0.0041
2014-04-11 2014-03-31 13F MYRIAD GENETICS COM 62855J104 8,240 3,040 58.46 282 158.72 0.0042
2014-01-06 2013-12-31 13F MYRIAD GENETICS COM 62855J104 5,200 0 0.00 109 -10.66 0.0019
2013-10-10 2013-09-30 13F MYRIAD GENETICS COM 62855J104 5,200 -280 -5.11 122 -17.01 0.0024
2013-07-09 2013-06-30 13F MYRIAD GENETICS COM 62855J104 5,480 5,480 147 0.0034
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-01-29 2014-12-31 13F MYRIAD GENETICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-10-10 2014-09-30 13F MYRIAD GENETICS COM Call 2,000 0.00 5 -44.44 n/a n/a n/a
2014-08-20 2014-06-30 13F MYRIAD GENETICS COM Call 2,000 9 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.